Logo for Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Investor Relations Material

Latest events

Logo for Regeneron Pharmaceuticals Inc

AGM 2025

Regeneron Pharmaceuticals
Logo for Regeneron Pharmaceuticals

AGM 2025

13 Jun, 2025
Logo for Regeneron Pharmaceuticals

Q1 2025

29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Regeneron Pharmaceuticals Inc

Access all reports
Regeneron Pharmaceuticals Inc is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company has a pipeline of product candidates comprising multiple therapeutic candidates in Phase I and Phase II clinical studies for the treatment of cancer, wet age-related macular degeneration and diabetic macular edema, atopic dermatitis, asthma, pain, and monoclonal antibodies.